Targeting fused in sarcoma (FUS): a novel antisense strategy for treating idiopathic pulmonary fibrosis

• Bhavika B. Katariya
• Shashipavan Chillappagari
• Poornima Mahavadi

Article 26 February 2026

Featured

• 

  Concordance analysis of DNA and RNA profiling: The MD Anderson IMPACT2 study in precision oncology

  • Stephanie T. Schmidt
  • Mehmet A. Baysal
  • Apostolia Maria Tsimberidou

  ArticleOpen Access24 Feb 2026
• 

  PKC-eta promotes breast cancer metastasis by regulating the Hippo–YAP signaling pathway

  • Vijayasteltar B. Liju
  • Kamran Waidha
  • Etta Livneh

  ArticleOpen Access17 Feb 2026
• 

  Cyclic di-GMP suppresses cancer metastasis by targeting proteasome 26S subunit non-ATPase 3 independently of STING

  • Jieqiong Wang
  • Alexander Mrozek
  • Hua Lu

  ArticleOpen Access04 Feb 2026
• 

  Cancer neuroscience: signaling pathways and new therapeutic strategies for cancer

  • Sihui Zhang
  • Lin Yuan
  • Yongye Huang

  Review ArticleOpen Access23 Feb 2026

Announcements

• 

  Behind the Paper

  In these Behind the Paper posts, our authors share the real stories behind the latest research papers, from conception to publication, the highs and the lows.

• 

  Cover Gallery

  Check out our journal covers and featured articles

• Published in partnership with West China Hospital, Sichuan University

  

Advertisement

Browse articles

• 

  Triggering multiple sclerosis: infection with Epstein-Barr virus activates multiple pre-existing autoreactive B and T cells

  • Edgar Meinl
  • Christian Münz

  Research HighlightOpen Access07 Apr 2026
• 

  Suppression of mitochondrial energy production by a photosynthetic bacterial cupredoxin peptide inhibits tumor growth

  • Samer A. Naffouje
  • Duy Binh Tran
  • Tohru Yamada

  ArticleOpen Access07 Apr 2026
• 

  Prostaglandin E₂-driven dedifferentiation of Schwann cells leads to perineural invasion in pancreatic ductal adenocarcinoma

  • Ling Wang
  • Qicai Liu
  • Jiahong Dong

  ArticleOpen Access07 Apr 2026
• 

  p53: from understanding its structure to advances in therapeutic targeting

  • Wenhua Wang
  • Xia Liu
  • Xianhuo Wang

  Review ArticleOpen Access06 Apr 2026
• 

  Activation of Nerve Growth Factor signaling limits the response to lenvatinib in hepatocellular carcinoma

  • Minghao Xu
  • Yimin Zheng
  • Jia Fan

  ArticleOpen Access05 Apr 2026
• 

  Winning the war against cancer in the precision era: it’s about time

  • Aditya Shreenivas
  • Adam Wahida
  • Razelle Kurzrock

  Research HighlightOpen Access02 Apr 2026
• 

  Acyl-CoA-binding protein (ACBP): a poor-prognosis biomarker in sepsis and a target for disease mitigation

  • Flavia Lambertucci
  • Omar Motiño
  • Guido Kroemer

  ArticleOpen Access02 Apr 2026
• 

  Glucocorticoids elevate clear cell renal cell carcinoma sensitivity to HIF-2α inhibitors by suppressing H4K12 lactylation

  • Kenan Zhang
  • Lin He
  • Luyang Sun

  ArticleOpen Access01 Apr 2026
• 

  (Giga)TIME for the era of AI: virtual multiplex immunofluorescence from routine H&E for large populations

  • Shao-Ping Yang
  • Dihua Yu

  Research HighlightOpen Access31 Mar 2026

Trending - Altmetric

• 

  Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases

• 

  Abrogation of aberrant glycolytic interactions eliminates senescent cells and alleviates aging-related dysfunctions

• 

  Gut microbiota modulation via repeated donor fecal transplantation improves motor and gastrointestinal symptoms in drug-naïve Parkinson’s disease: a randomized phase 2 trial

• 

  Oligodendrocyte precursor cells–microglia crosstalk via BMP4 drives microglial neuroprotective response and mitigates Alzheimer’s disease

• 

  This journal is a member of and subscribes to the principles of the Committee on Publication Ethics.

•